文献速递消化道肿瘤与早癌炎症性肠病

树突状细胞FFAR2缺失促进小鼠结肠肿瘤发生

Expression of Free Fatty Acid Receptor 2 by Dendritic Cells Prevents Their Expression of Interleukin 27 and Is Required for Maintenance of Mucosal Barrier and Immune Response Against Colorectal Tumors in Mice.
PubMed 文献 · Gastroenterology · 2020-01-07

该研究利用ApcMin/+小鼠及Ffar2条件性敲除小鼠,探究短链脂肪酸受体FFAR2在结直肠癌中的作用。结果显示,FFAR2缺失通过降低肠道屏障完整性、增加肿瘤细菌负荷、促进CD8+T细胞耗竭及树突状细胞过度活化产生IL27,促进结肠肿瘤发生;IL27抗体和FFAR2激动剂可减少小鼠肿瘤。

要点

  • 树突状细胞FFAR2缺失导致IL27产生增加,促进CD8+T细胞耗竭。
  • FFAR2缺失增加肠道通透性和肿瘤细菌负荷,加速肿瘤发生。
  • IL27抗体或FFAR2激动剂可减少小鼠结肠肿瘤,具治疗潜力。

核心结论

  • FFAR2缺失通过降低肠道屏障完整性、增加肿瘤细菌负荷、促进CD8+T细胞耗竭及树突状细胞过度活化产生IL27,促进小鼠结肠肿瘤发生。

研究设计与样本

  • 研究使用ApcMin/+小鼠、ApcMin/+Ffar2-/-小鼠、Ffar2fl/flCD11c-Cre小鼠、ApcMin/+Ffar2fl/flCD11c-Cre小鼠及Ffar2fl/fl对照小鼠,部分给予葡聚糖硫酸钠诱导结肠炎,并联合FFAR2激动剂或IL27抗体处理。

主要发现

  • ApcMin/+Ffar2-/-小鼠自发性结肠肿瘤显著多于ApcMin/+小鼠,且肿瘤发生前肠道通透性增加,伴E-钙黏蛋白表达降低。
  • ApcMin/+Ffar2-/-小鼠结肠肿瘤中细菌数量高于ApcMin/+小鼠,CD39+CD8+T细胞及耗竭或濒死T细胞频率更高。
  • ApcMin/+Ffar2-/-小鼠树突状细胞活化状态改变、死亡增加且IL27产生增多。
  • 给予IL27抗体可减少结肠炎ApcMin/+小鼠的结肠肿瘤数量。
  • Ffar2fl/flCD11c-Cre小鼠结肠炎结肠固有层中CD39+CD8+T细胞和IL27+树突状细胞频率高于对照组或无结肠炎小鼠。

临床怎么用

  • IL27抗体和FFAR2激动剂在小鼠中减少肿瘤发生,可能被开发用于结直肠癌治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Intestinal microbes and their metabolites affect the development of colorectal cancer (CRC). Short-chain fatty acids are metabolites generated by intestinal microbes from dietary fiber. We investigated the mechanisms by which free fatty acid receptor 2 (FFAR2), a receptor for short-chain fatty acids that can affect the composition of the intestinal microbiome, contributes to the pathogenesis of CRC. METHODS: We performed studies with ApcMin/+ mice, ApcMin/+Ffar2-/- mice, mice with conditional disruption of Ffar2 in dendritic cells (DCs) (Ffar2fl/flCD11c-Cre mice), ApcMin/+Ffar2fl/flCD11c-Cre mice, and Ffar2fl/fl mice (controls); some mice were given dextran sodium sulfate to induce colitis, with or without a FFAR2 agonist or an antibody against interleukin 27 (IL27). Colon and tumor tissues were analyzed by histology, quantitative polymerase chain reaction, and 16S ribosomal RNA gene sequencing; lamina propria and mesenteric lymph node tissues were analyzed by RNA sequencing and flow cytometry. Intestinal permeability was measured after gavage with fluorescently labeled dextran. We collected data on colorectal tumors from The Cancer Genome Atlas. RESULTS: ApcMin/+Ffar2-/- mice developed significantly more spontaneous colon tumors than ApcMin/+ mice and had increased gut permeability before tumor development, associated with reduced expression of E-cadherin. Colon tumors from ApcMin/+Ffar2-/- mice had a higher number of bacteria than tumors from ApcMin/+ mice, as well as higher frequencies of CD39+CD8+ T cells and exhausted or dying T cells. DCs from ApcMin/+Ffar2-/- mice had an altered state of activation, increased death, and higher production of IL27. Administration of an antibody against IL27 reduced the numbers of colon tumors in ApcMin/+ mice with colitis. Frequencies of CD39+CD8+ T cells and IL27+ DCs were increased in colon lamina propria from Ffar2fl/flCD11c-Cre mice with colitis compared with control mice or mice without colitis. ApcMin/+Ffar2fl/flCD11c-Cre mice developed even more tumors than ApcMin/+Ffar2fl/fl mice, and their tumors had even higher numbers of IL27+ DCs. ApcMin/+ mice with colitis given the FFAR2 agonist developed fewer colon tumors, with fewer IL27+ DCs, than mice not given the agonist. DCs incubated with the FFAR2 agonist no longer had gene expression patterns associated with activation or IL27 production. CONCLUSIONS: Loss of FFAR2 promotes colon tumorigenesis in mice by reducing gut barrier integrity, increasing tumor bacterial load, promoting exhaustion of CD8+ T cells, and overactivating DCs, leading to their death. Antibodies against IL27 and an FFAR2 agonist reduce tumorigenesis in mice and might be developed for the treatment of CRC.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Lavoie S, Chun E, Bae S, et al. Expression of Free Fatty Acid Receptor 2 by Dendritic Cells Prevents Their Expression of Interleukin 27 and Is Required for Maintenance of Mucosal Barrier and Immune Response Against Colorectal Tumors in Mice. Gastroenterology. 2020. PMID: 31917258. doi:10.1053/j.gastro.2019.12.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。